Cutler Group’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

Cutler Group’s Portfolio VCNX Stock Details VCNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-42	Closed	-$1K	–	6523
2021 Q1	$1K	Buy	+42	New	+$27K	﹤0.01%	5433

Other funds holding VCNX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cutler Group's VCNX Position: Q3 2021 in Review

Cutler Group sold out of Vaccinex, Inc. Common Stock (VCNX) in Q3 2021, closing a stake of 6 shares — an estimated $2.99K sold.

Cutler Group first reported a position in VCNX in Q2 2021 and held it in 1 quarter. The position peaked at $3K in Q2 2021. 21 funds tracked by Wall St. Rank hold VCNX as of Q3 2021.

Cutler Group reported no remaining Vaccinex, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Cutler Group sold 6 Vaccinex, Inc. Common Stock shares in Q3 2021, an estimated $2.99K.
Cutler Group first reported a position in Vaccinex, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
Cutler Group's Vaccinex, Inc. Common Stock position peaked at $3K in Q2 2021.
21 funds tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q3 2021.

Based on Cutler Group's 13F filing for Q3 2021, filed 26 Oct 2021.